Evommune, Inc. Raises $12.5M in Seed Funding to Accelerate the Development of Transformative Medicines for Chronic Inflammatory Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3nC6oge
via IFTTT